Enzo Biochem (ENZ) executive Bench bought 3,500 shares for $7,525 at $2.15

Insider transactions reported

David Bench (executive at Enzo Biochem Inc., ENZ) reported that they bought 3,500 shares for $7,525 at $2.15 on Jun 14, 2022. After these transactions the filing shows 6,000 shares held indirectly (By Trust (PSP)).

Reporting person

Bench David

Holdings before and after

• Common Stock, $0.01 Par Value: 2,500 to 6,000 indirect, By Trust (PSP)

Other positions listed

• Common Stock, $0.01 Par Value: 4,138 indirect, 401k

Footnotes from the filing

1. 1. Represents shares held by David Bench Consulty Group, a profit sharing plan of which the reporting person is a participant.
2. 2. Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
3. 3. The stock options have a five-year term and will vest in three equal instalments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.

Transaction codes in this filing

Open-market purchase:

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ